Clinical Trial Update: China S3 PMS: SAPIEN 3 China Post Market Registry Study

View source ↗

Summary

This clinical trial update reports on the SAPIEN 3 China Post-Market Registry study, an ongoing registry evaluating the SAPIEN 3 transcatheter heart valve for s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• SAPIEN 3 (transcatheter aortic valve)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Stenosis, Severe | Status: ACTIVE_NOT_RECRUITING